Glaxo Highlights Tykerb Cancer Drug
30th Nov 2005, 21:25 GMT
GlaxoSmithKline expects to have seven major drugs in the final stage of development in the coming months. It may seek approval for its Tykerb breast-cancer drug by late next year.
Glaxo Highlights Tykerb Cancer Drug related news:
- Glaxo sees 4 cancer drugs in final trials in 2006 — RedOrbit News - Health
- Glaxo looks to become cancer drug leader — CNNmoney.com - International News
- Glaxo Bullish on Cancer Drugs — Red Herring
- Breast Cancer Drug Costs 'Could Double' Report Highlights Financial Burden of Using Herceptin — RedOrbit News - Health
- Glaxo to put 4 new cancer drugs into final trials — Reuters: Health
- Glaxo to put 4 new cancer drugs into final trials (Reuters) — Yahoo! News: Health News
- Glaxo to put cancer drugs into final trials — Reuters: Business
- Cancer Drug No Fertility Treatment — Health News: CBSnews.com
- New breast cancer drug shows promise — The Cancer Blog
- Cancer Drug Green Light — RedOrbit News - Health
Latest news from WSJ.com: US Business:
- Merck's Arcoxia Draws Mixed Reviews
- Benetton Top Executives Resign
- Apple Names Rosenberg General Counsel
- Gutierrez Aims to Help U.S. Business in China
- Tyson Swings to Loss as Demand Wanes
- Eddie Bauer Agrees to Be Acquired
- Web Companies Seek Review of Fees
- Delta Cuts Bargain Fares
- Illumina to Buy Solexa for $600 Million
- BlackJack Is BlackBerry's Newest Rival